Role Of Deep Learning Applications In Pathology To Speed Up Drug Discovery And Development
AIRA Matrix CEO, Chaith Kondragunta will be speaking at Intelligent Health 2021 on the application of Deep Learning applications that speed up the preclinical phase of drug discovery and development.
The Tech Talk titled “Using Deep Learning applications in pathology to speed up drug discovery and development” will focus on our AI solutions that significantly mitigate risks and reduce costs at various stages of the drug development funnel.
“Processes in preclinical drug development are time-consuming and labor-intensive and are relatively unexplored for the application of AI techniques. Our comprehensive AI solutions are designed to help process outcomes in this phase,” said Chaith Kondragunta.
To gain deeper insights on our novel solutions that optimize time and resources to help bring safe, efficacious drugs to market in a shorter time, register to Intelligent Health 2021 at https://intelligenthealth.ai/tickets/.
About AIRA Matrix:
AIRA Matrix provides AI-based image analysis solutions and image management systems for Life Sciences applications. Our solutions improve efficiency, diagnostic accuracy, and turnaround times in pathology, microbiology, and ophthalmology workflows across pharmaceutical and healthcare laboratories.
We leverage machine and deep learning techniques to develop diagnostic, prognostic, and predictive solutions. Our clients and partners include leading hospitals, pharmaceutical companies, CROs, and research labs around the world.
For enquiries and demos, do contact us at info@airamatrix.com.
Source: AIRA Matrix
